1. Introduction {#sec0001}
===============

Over the past few decades, particulate systems such as microparticles (MPs) and nanoparticles (NPs) have been extensively studied for biomedical applications including targeted drug delivery, imaging, and diagnostics [@bib0001], [@bib0002], [@bib0003], [@bib0004]. In designing the MPs and NPs, a majority of studies has focused on the particle size, surface chemistry, and material composition to control particle properties [@bib0005], [@bib0006], [@bib0007], [@bib0008], [@bib0009]. In recent years, the particle shape has emerged as a critical parameter that modulates an interplay between a particle and a biological milieu [@bib0010], [@bib0011]. In this regard, attention has been given to the use of non-spherical shapes in the design of drug delivery carriers as a strategy to overcome certain limitations associated with spherical systems. In particular, shapes inspired by the diverse, evolutionarily conserved shapes of pathogens and cells are being used to evaluate the effects of carrier shapes on cellular uptake, *in vivo* transport, and organ distribution [@bib0012].

Non-spherical particles such as rods and disk have been shown to enable superior biological performance compared to their spherical counterparts. Several theoretical and *in vitro* models have predicted increased margination of non-spherical particles compared to spherical particles to blood vessel walls due to hydrodynamic interactions that propel non-spherical particles towards the wall during blood flow [@bib0013], [@bib0014]. In addition, non-spherical particles showed reduced immune clearance as compared to spherical ones [@bib0015]. Other unique properties of non-spherical particles include their binding ability to target cells and rapid internalization, compared with spherical ones [@bib0016]. Non-spherical particles also exhibited longer blood-circulation times and improved tumor accumulation in solid tumors in comparison with their spherical counterparts [@bib0017], [@bib0018], [@bib0019].

Given the aforementioned unique properties of non-spherical shapes, several different shape-engineering techniques have been developed; these methods include non-wetting templates, microfluidic systems, template assemblies, and a film stretching [@bib0020], [@bib0021], [@bib0022]. Among the fabrication methods, the film stretching method has been considered a simple, versatile, inexpensive, and high-throughput method [@bib0023], [@bib0024]. In the film stretching method, different non-spherical shapes can be fabricated by immobilization of polymeric particles in a polyvinyl alcohol (PVA) film, heating the film above the glass transition temperature of polymeric particles, followed by stretching to deform the particles. The film stretching method has been widely used for the investigation of shape effects on drug delivery applications such as particle-cell interactions, drug release, vaccine delivery, cellular trafficking [@bib0024], [@bib0025], [@bib0026].

Recently, shape effect on targeting efficacy of NPs in the presence of surface ligands has gained much attention. Several studies found that interplay between shape and surface targeting ligand in NP is of importance in particle-cell interaction including NP binding to cells and cellular uptake [@bib0027]. Barua et al. demonstrated that trastuzumab-coated rod-shaped polystyrene NPs exhibited higher specific and lower nonspecific uptake in breast cancer cells than did spherical counterparts [@bib0028]. In another study, Poornima et al. demonstrated that the shape of ligand-displaying nanoparticles enhances the specificity of endothelial targeting [@bib0029]. In the studies, polystyrene-based nanoparticles were used to fabricate non-spherical NPs by a PVA film stretching method and the targeting ligands were coated on the surfaces by simple physical adsorption. However, the polystyrene is neither biodegradable nor biocompatible, thus limiting clinical applications. One promising alternative to polystyrene is poly (lactic-co-glycolic acid) (PLGA), an FDA-approved biodegradable polymer, that has long been used for drug delivery due to its biocompatibility, safety for human use, and ability to release encapsulated drugs in a controlled manner [@bib0030]. However, physical adsorption of targeting ligands to the negatively charged PLGA particles is inefficient due to the difficulties associated with controlling the molecular orientation of physically bound ligands [@bib0031]. Moreover, use of PVA film for the stretching process results in the residual PVA on the surface of PLGA NPs, which represents a barrier against the covalent ligand conjugation because it shields the functional group of PLGA (i.e. carboxylic group) [@bib0032], [@bib0033].

In this study, surface-conjugatable non-spherical PLGA NPs with a sufficient number of carboxylic acids on the surface were developed. To increase the number of carboxylic acid groups immobilized to the surface of non-spherical PLGA particles, the PVA film was replaced with poly (ethylene-alt-maleic acid; PEMA) film bearing carboxylic acid side chains ([Fig. 1](#fig0001){ref-type="fig"}). Rod-shaped PLGA MPs (microrods) and NPs (nanorods) were fabricated by the PEMA film-based stretching method. Two model ligands, fluorescein isothiocyanate (FITC)-conjugated albumin and transferrin (Tf), were conjugated on the particle surfaces. The presence of surface carboxylic acid groups was determined by confocal microscopy and zeta potential measurements. Cellular uptake of Tf-conjugated nanorods by KB human carcinoma cells was also evaluated.Fig. 1Fabrication of surface-conjugatable, microrods and nanorods by PEMA film stretching.Fig 1

2. Materials and methods {#sec0002}
========================

2.1. Materials {#sec0003}
--------------

PLGA (50:50 DLG 5E, intrinsic viscosity 0.47 dL/g; PLGA-ester (with ester terminated end) and 50:50 DLG 4A, intrinsic viscosity 0.38 dL/g; PLGA-acid (with acid terminated end)) was purchased from Lakeshore Biomaterials (Birmingham, AL, USA). PVA, PEMA, *N*-hydroxysuccinimide (NHS), *N*-(3-dimethylaminopropyl)-*N*′-ethylcarbodiimide hydrochloride (EDC), and FITC-albumin were purchased from Sigma-Aldrich (St. Louis, MO, USA). Tf was purchased from Athens Research & Technology (Athens, GA, USA). All other chemicals used were of analytical grade.

2.2. Particle preparation {#sec0004}
-------------------------

PLGA nanospheres and microspheres were fabricated by the oil-in-water emulsion solvent-evaporation method [@bib0034]. For nanospheres preparation, 50 mg of PLGA was dissolved in 5 ml of methylene chloride. For the uptake study, 0.1 mg of coumarin-6 (C6) was added to this solution. The organic phase was mixed with 1% (w/v) PVA or 1% (w/v) PEMA solution (20 ml) and then was emulsified using a probe sonicator (KFS-300N ultrasonic processor, Korea Process Technology, Korea) at a power of 100 W for 1 min in an ice bath. The resultant emulsion was mechanically stirred for 3 h at 500 rpm in a fume hood to remove residual organic solvents. Nanospheres were collected by centrifugation at 20 000 × g for 1 h and then washed three times with double-distilled water. For microspheres preparation, 100 mg of PLGA was dissolved in 3 ml of methylene chloride. This organic phase was mixed with 1% (w/v) PVA or 1% (w/v) PEMA solution (20 ml) and then emulsified for 5 min, using a homogenizer with a stirring rate of 2,000 rpm in an ice bath. The resultant emulsion was mechanically stirred for 3 h at 500 rpm in a fume hood to remove residual organic solvents. Microspheres were collected by centrifugation at 200 × g for 30 min and were washed 3 times using double-distilled water.

2.3. Surface-conjugatable microrods and nanorods preparation {#sec0005}
------------------------------------------------------------

Microrods were prepared by the previously reported film-stretching method with some modification ([Fig. 1](#fig0001){ref-type="fig"}) [@bib0023]. To fabricate the stretching film, 10% (w/v) PVA and 10% (w/v) PEMA were initially blended at different ratios, after which PLGA-acid/PVA (polymer: PLGA-acid, surfactant: PVA), PLGA-acid/PEMA (polymer: PLGA-acid, surfactant: PEMA), PLGA-ester/PVA (polymer: PLGA-ester, surfactant: PVA), and PLGA-ester/PEMA (polymer: PLGA-ester, surfactant: PEMA) were added to the mixtures. The film was dried on square dishes for 15 h in an incubator at 37 °C. The dried film was cut into 2.5 × 5 cm^2^ sections and mounted on a custom axial-made stretcher. The film was stretched in mineral oil at 58--64 °C at a rate of 0.5--1.0 mm/s. After stretching, each film was stored in cold mineral oil for 5 min to lower the temperature and washed with ethyl ether to remove residual oil. Each film was then dissolved in double-distilled water and the stretched particles were collected by centrifuging for 1 h at 200 × g, followed by washing 5 times with double-distilled water. Nanorods were also prepared according to the film-stretching method (80% PEMA film) with the exception that the nanoparticles were added to the mixtures to make the film.

2.4. Immobilization of Tf and FITC-albumin to the surfaces of microrods and nanorods {#sec0006}
------------------------------------------------------------------------------------

Tf and FITC-albumin were conjugated onto the surfaces of microrods or nanorods using carbodiimide chemistry. Particles (20 mg) were dispersed in 5 ml of 2-(N-morpholino)ethanesulfonic acid (MES) buffer (0.1 M, pH 5.5) and then reacted with 200 µl of EDC (10 mg/ml) and 200 µl of NHS (10 mg/ml) for 2 h. Excess unreacted EDC and NHS were removed by 3 rounds of washing with MES buffer and centrifugation. The particles with activated carboxyl groups were dispersed in 6 ml of phosphate-buffered saline (PBS, pH 7.4), and then reacted with 300 µl of FITC-albumin (1.0 mg/ml in PBS) or Tf (10.0 mg/ml in PBS) for 4 h in the dark at room temperature. Excess unconjugated Tf and FITC-albumin were removed by three rounds of centrifugation at 20,000 × g for 30 min in PBS buffer. Tf and FITC-albumin adsorption to particle surfaces were performed as described for the conjugation experiments, except that MES buffer was used instead of the EDC and NHS solutions.

2.5. Determination of Tf and FITC-albumin on the surfaces of microrods and nanorods {#sec0007}
-----------------------------------------------------------------------------------

The conjugation of FITC-albumin to the surfaces of microrods was visualized by confocal microscopy (Fluoview FV10i, Olympus, Tokyo, Japan). The fluorescence intensities of FITC-albumin-conjugated nanorods were measured on a multimode microplate reader (TriStar LB 941, Berthold Technologies, Bad Wildbad, Germany), using excitation and emission wavelengths of 460 nm and 540 nm, respectively. Unconjugated free Tf proteins in the supernatants were quantified using a BCA Assay Kit (Fisher Scientific, Waltham, MA, USA). The quantities of Tf on the nanorods surfaces were calculated by subtracting the free protein in the supernatants from the original amount added.

2.6. Scanning-electron microscopy (SEM) {#sec0008}
---------------------------------------

Microrods and nanorods were characterized by field-emission SEM (FE-SEM, S4800, Hitachi, Japan). The particles were dispersed in double-distilled water, dropped onto a carbon tape, and then dried in a fume hood and desiccator. The carbon tapes with PLGA particles were coated with platinum for 2 min under a vacuum. The samples were viewed by FE-SEM, under acceleration voltages of 5 kV and 35 kV. Particle sizes were measured using ImageJ software (NIH, Bethesda, MD, USA; *n* = 100).

2.7. Zeta potential {#sec0009}
-------------------

The zeta potential distribution was measured using a Zetasizer Nano ZS (Malvern Instruments, Malvern, UK). Samples were diluted in double-distilled water and placed in a zeta cell. The average of three measurements of each sample was used to derive the average zeta potential.

2.8. Confocal microscopy {#sec0010}
------------------------

Human epidermoid cancer KB cells were grown in RPMI 1640supplemented with 10% (v/v) fetal bovine serum and antibiotics (100 IU/ml of penicillin G sodium and 100 µg/ml of streptomycin sulfate). Cells were maintained in an incubator supplied under a humidified 5% CO~2~/95% air atmosphere at 37 °C. KB cells were seeded on cover glasses in a 6-well plate at an initial density of 5 × 10^4^ cells /well. The cells were incubated with Tf-conjugated and C6-loaded nanorods fabricated using PVA and PEMA. After 2 h, the cells were washed several times with cold PBS and fixed with 4% paraformaldehyde for 10 min. The cells were washed twice with cold PBS and then incubated with 0.1% Triton X-100 in 0.2 N NaOH for 5 min. The nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI; 2 µg/ml) for 5 min, the cells fixed with Permount Mounting Medium (Fisher Scientific), and then observed by confocal microscopy (Fluoview FV10i).

2.9. Statistical analysis {#sec0011}
-------------------------

Statistical analysis was performed using the paired *t*-test in SigmaPlot 12.0 (SYSTAT, Inc., Chicago, IL, USA). Results are expressed as means ± SD. Statistical significance was accepted for *P* values \< 0.05.

3. Results and discussion {#sec0012}
=========================

3.1. Preparation of PLGA microrods and nanorods {#sec0013}
-----------------------------------------------

The purpose of this study was to develop a modifiable surface of non-spherical biodegradable NPs prepared by a film stretching method for use as a drug delivery system. Introduction of a functional group, such as a carboxylate group, to non-spherical particles made by the conventional PVA film stretching method, has been limited due to the residual PVA on the surface. In this study, however, we utilized the property of residual film composition to fabricate a surface-conjugatable non-spherical NPs. PEMA has been used as a surfactant during particles fabrication to increase the number of carboxyl groups on the surface of PLGA particles for surface modification [@bib0035]. If PEMA was used as a stretching film to fabricate non-spherical NPs, non-spherical NPs with abundant conjugatable surface functional groups can be fabricated. Fabrication of surface-modifiable, microrods and nanorods using PEMA film was illustrated in [Fig. 1](#fig0001){ref-type="fig"}. In order to see whether we can increase the amount of carboxyl groups on the surface of microrods by increasing the amount of carboxyl groups on the surface of microspheres, four different microspheres (PLGA-acid/PVA, PLGA-acid/PEMA, PLGA-ester/PVA and PLGA-ester/PEMA) were fabricated using the oil-in-water emulsion solvent-evaporation method. It is worth to note that there are two types of PLGA end groups (acid-end and ester-end). Unlike PLGA-ester, PLGA-acid has end carboxylic groups, which could potentially increase the availability of carboxylic groups in the surface of non-spherical particles after the film stretching [@bib0036]. Likewise, we also compared two surfactants, PVA and PEMA. As compared to PVA, PEMA has carboxylic groups, thus it may also increase the availability of carboxylic groups at the final non-spherical particles. Four different microspheres were converted to microrods by the film stretching method and their aspect ratios were evaluated.

[Fig. 2](#fig0002){ref-type="fig"} shows the SEM images of microrods fabricated with different ratios of PEMA and PVA with four differently formulated microspheres. First, the microrods were fabricated by the 100% PVA film (called hereafter PVA film) as a control for comparative studies. Four PLGA microrods with the same aspect ratio (rod length divided by diameter) of 5 were observed by using PVA film. The PLGA and surfactants types have no effect on the aspect ratio of microrods. Second, we attempted to fabricate microrods using 100% PEMA film; however, the use of 100% PEMA film resulted in an incomplete stretching as determined by SEM in [Fig. 2](#fig0002){ref-type="fig"}, indicating the difficulty in fabricating microrods using 100% PEMA film. It could be because the force holding the particles in the PEMA film was lower than that operating in the PVA film. At last, PEMA was blended with PVA at different ratios. We found that 50% PEMA film and 80% PEMA film resulted in microrods with similar aspect ratios with PVA film, indicating that successful fabrication of microrods. For further studies, we selected the 80% PEMA film (called hereafter PEMA film) because high carboxylate group densities are required on the particle surface for modification of the nanorods by ligand conjugation.Fig. 2SEM images of microrods fabricated using different proportions of PEMA and PVA with four differently formulated microspheres. The scale bars are 10 µm.Fig 2

3.2. Determination of carboxyl groups on the surface of microrods {#sec0014}
-----------------------------------------------------------------

For detection of the surface carboxyl groups, we conjugated FITC-albumin to the surface of microrods using a carbodiimide chemistry-based method. Using EDC and NHS as chemical crosslinkers, the surface carboxyl groups of the PLGA microrods were activated so that they could bind covalently to the terminal amine group of FITC-albumin. The amount of FITC- albumin coating on the surface of microrods was assessed by monitoring the fluorescence changes in confocal microscopy. [Fig. 3](#fig0003){ref-type="fig"} shows confocal images of microrods with FITC-albumin conjugated to their surfaces. We fabricated 8 kinds of microrods using PVA film and PEMA film. The FITC channel revealed the green fluorescence of FITC-albumin. The microrods fabricated by using PEMA film exhibited high fluorescence levels, whereas none of the microrods fabricated using the PVA film exhibited fluorescence. PLGA-acid and PEMA surfactant did not increase the fluorescence levels, indicating using PLGA-acid as a polymer and PEMA as a surfactant do not increase the availability of surface carboxyl groups. These results demonstrated that, when using PEMA film, we could fabricate microrods with surface carboxyl groups regardless of end groups of PLGA and surfactant types.Fig. 3Confocal images of microrods with surface-conjugated FITC-albumin. Scale bars in bright field (BF) images correspond to 5 µm.Fig 3

3.3. Zeta potentials {#sec0015}
--------------------

We analyzed the zeta potentials of microrods using a Zetasizer Nano ZS system to further confirm the presence of surface carboxyl groups on the microrods. It is worth noting that the terminal carboxyl groups on the surface decrease the zeta potentials. As shown in [Fig. 4](#fig0004){ref-type="fig"}, when PEMA was used as a surfactant to prepare microspheres, the zeta potential of microspheres was nearly −40 mV. Whereas the zeta potential of microspheres prepared with PVA as a surfactant was approximately −20 mV. The zeta potential of microspheres fabricated using PLGA-ester was higher than those fabricated using PLGA-acid. In general, surfactant-free PLGA NPs exhibit a negative zeta potential (−49 mV) due to the presence of terminal carboxylic groups in PLGA [@bib0037]. A residual surfactant on the particle surface can affect the zeta potential. Microspheres prepared using PVA as a surfactant show a low negative charge due to hydroxyl groups (-OH) of PVA, whereas ones prepared using PEMA show high negative charge due to carboxyl groups (-COOH) of PEMA [@bib0038]. The PLGA type had little effect on the zeta potential of microspheres although the value obtained using PLGA-acid was somewhat higher than that obtained using PLGA-ester. After film-stretching using PVA film, the zeta potential of all of the microrods became approximately −20 mV; however, the zeta potential of microrods after film-stretching with PEMA film was nearly −40 mV. We found that the factor that determines the zeta potential of microrods was the film composition during particle stretching, not the type of PLGA nor surfactants used during the microsphere preparation.Fig. 4The surface charge of PLGA MPs. Results are expressed as the means ± SD (*n* = 3).Fig 4

3.4. Characterization of nanorods {#sec0016}
---------------------------------

PLGA NPs have been used as drug delivery systems in various biomedical applications involving cancer, inflammation, and other diseases, because of their versatility in terms of biocompatibility, drug-loading ability, and controlled-drug release [@bib0039]. A wide range of pharmaceuticals such as hydrophilic or hydrophobic small molecules or macromolecules has been delivered via PLGA NPs [@bib0040]. By the PEMA-based film stretching method, surface-modifiable nanorods were also successfully fabricated. [Fig. 5](#fig0005){ref-type="fig"} shows SEM images of nanorods fabricated using both PVA film and PEMA film. SEM images showed that the nanorods exhibited a regular rod shape and uniform size without any noticeable pinholes or cracks and with a narrow size distribution**.** The properties of nanorods are summarized in [Table 1](#tbl0001){ref-type="table"}. The mean size of the nanorods was 373.2 nm × 98.7 nm for PVA film and 385.8 nm × 105.9 nm for PEMA film, resulting in an average aspect ratio of 4. Their mean zeta potentials were −19.5 and −38.5 mV, respectively, which are consistent with results from microrods.Fig. 5SEM images of nanorods. The dimensions of nanorods fabricated using PVA film were 373.2 ± 97.5 nm (length) by 98.7 ± 18.5 nm (width), while those of nanorods fabricated using PEMA film were 385.8 ± 88.2 nm (length) by 105.9 ± 25.7 nm (width). The scale bars are 1 µm.Fig 5Table 1Physicochemical characteristics of nanorods.Table 1Table 1FormulationParticle dimension (length × width, nm)Zeta potential (mV)Nanorods (PVA film)373.2 ± 97.5 × 98.7 ± 18.5--18.5 ± 0.9Nanorods (PEMA film)385.8 ± 88.2 × 105.9 ± 25.7--38.5 ± 0.5[^2]

3.5. Determination of Tf and FITC-albumin on the surfaces of nanorods {#sec0017}
---------------------------------------------------------------------

To determine the feasibility of nanorods for surface modification, the capacity for protein immobilization on the surface of nanorods fabricated using either PVA film or PEMA film was tested using Tf and FITC-albumin. Two strategies for attaching proteins to nanorods were used: conjugation and adsorption. [Fig. 6](#fig0006){ref-type="fig"}A shows the amount of surface-conjugated Tf and FITC-albumin on nanorods. The amount of protein conjugated to the surface of nanorods generated using PEMA film was ∼70 µg/mg NPs. However, when PVA film was used, the amount of Tf and protein on the surface of nanorods was only ∼20 µg/mg NPs regardless of binding methods. [Fig. 6](#fig0006){ref-type="fig"}B shows the fluorescence intensities of nanorods fabricated using different film types. The fluorescence came from FITC-albumin, which was conjugated on the surface of nanorods. Nanorods fabricated using PEMA film show over 3-fold higher fluorescence intensities than ones fabricated using PVA film, which is consistent with result of the amount of protein on the nanorods, indicating that the Tf and FITC-albumin on the surface of nanorods fabricated using PVA were not conjugated but merely adsorbed, proving that residual PVA from PVA film is a potential barrier against ligand conjugation to the particle surface. Thus, PVA film is not appropriate for surface ligand conjugation of non-spherical particles. Overall, PEMA film is the optimal film for fabricating non-spherical particles with a high capacity of surface ligand conjugation.Fig. 6Amount of protein on the particle surface (A) and fluorescence intensities (B) of nanorods fabricated using different film types. The results are expressed as the mean ± SD (*n* = 3). \**P* \< 0.05 vs. nanorods fabricated using PVA film.Fig 6

3.6. Cellular uptake {#sec0018}
--------------------

The delivery of drugs into specific cell types can significantly reduce drug toxicity and increase their therapeutic effects [@bib0041], [@bib0042]. Various targeting ligands have been utilized to increase the intracellular uptake of NPs [@bib0043]. Among them, Tf is a widely used targeting ligand for tumor-targeted delivery. The extent of the cellular uptake of nanorods conjugated with the Tf was investigated in KB cells which overexpresses Tf receptors. [Fig. 7](#fig0007){ref-type="fig"} shows the cellular-uptake of Tf-conjugated coumarin-6-loaded nanorods (fabricated using PVA and PEMA) in KB cells. The blue fluorescence by the nuclear dye DAPI, which did not co-localize with green fluorescence representing the nanorods internalized to the cytoplasm. Nanorods fabricated using PEMA film exhibited even higher intracellular accumulation as compared to those fabricated using PVA film. The cellular uptake of NPs can be viewed as a two-step process: a binding step on the cell membrane and an internalization step [@bib0044] Interactions between ligand-modified NPs and cellular receptors depend on the molecular orientation and ligand density on the NPs surface. The nanorods fabricated using PEMA film have more ligands conjugated to the surface of nanorods. As shown in the [Fig. 7](#fig0007){ref-type="fig"}**,** Tf-nanorods (PEMA film) have strong binding affinity to the Tf receptor on the cell membrane compare to Tf-nanorods (PVA film) because of multiple receptor-ligand complexes at the cell surface. Receptor-mediated endocytosis has been shown to facilitate and promote particle penetration into cells when Tf was conjugated on the surface of NPs [@bib0045]. These results demonstrated the advantage of the surface-modifiable nanorods in targeted drug delivery.Fig. 7Confocal microscopy image of cellular-uptake studies of Tf-conjugated, coumarin-6-loaded, nanorods (fabricated using PVA and PEMA) in KB cells after a 2-h incubation. The scale bars are 10 µm.Fig 7

4. Conclusion {#sec0019}
=============

In this study, surface-conjugatable, micro- and nanorods were successfully fabricated by the PEMA-based film-stretching method. The film type was identified as the key factor facilitating the fabrication of surface-conjugatable non-spherical particles. FITC-albumin and Tf were successfully conjugated to the surfaces of nanorods, demonstrating that the system has the ability to enhance surface ligand conjugation. Furthermore, Tf-conjugated nanorods fabricated using PEMA film exhibited higher binding and cellular uptake in KB cell than those fabricated using PVA film. Therefore, the PEMA-based film-stretching system presented in this study would be a promising fabrication method for non-spherical biodegradable polymeric micro- and nanoparticles with high capacity of surface modifications for enhanced targeted delivery.
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